Latest & greatest articles for anticoagulation

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on anticoagulation or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on anticoagulation and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for anticoagulation

1. Aspirin versus anticoagulation in cervical artery dissection (TREAT-CAD): an open-label, randomised, non-inferiority trial

Aspirin versus anticoagulation in cervical artery dissection (TREAT-CAD): an open-label, randomised, non-inferiority trial Aspirin versus anticoagulation in cervical artery dissection (TREAT-CAD): an open-label, randomised, non-inferiority trial - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Clipboard, Search History, and several other advanced features are temporarily unavailable. COVID-19 Information Show account info (...) displayed: Create RSS Cancel RSS Link Copy Actions Cite Display options Display options Format Share Permalink Copy Page navigation Randomized Controlled Trial Lancet Neurol Actions . 2021 May;20(5):341-350. doi: 10.1016/S1474-4422(21)00044-2. Epub 2021 Mar 23. Aspirin versus anticoagulation in cervical artery dissection (TREAT-CAD): an open-label, randomised, non-inferiority trial , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Collaborators, Affiliations Expand Collaborators

2021 EvidenceUpdates

2. Role of combining anticoagulant and antiplatelet agents in COVID-19 treatment: a rapid review. Full Text available with Trip Pro

Role of combining anticoagulant and antiplatelet agents in COVID-19 treatment: a rapid review. Role of combining anticoagulant and antiplatelet agents in COVID-19 treatment: a rapid review - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Clipboard, Search History, and several other advanced features are temporarily unavailable. COVID-19 Information Show account info Close Account Logged in as: username Search: Search Save (...) options Display options Format Share Permalink Copy Page navigation Review Open Heart Actions . 2021 Jun;8(1):e001628. doi: 10.1136/openhrt-2021-001628. Role of combining anticoagulant and antiplatelet agents in COVID-19 treatment: a rapid review , , , , , Affiliations Expand Affiliations 1 Lebanese American University Medical Center, Rizk Hospital, Beirut, Lebanon. 2 Department of Sciences, Lebanese University, Beirut, Lebanon. 3 School of Medicine, Lebanese American University, Byblos, Lebanon. 4

2021 EvidenceUpdates

3. Andexanet alfa for reversing anticoagulation from apixaban or rivaroxaban

Andexanet alfa for reversing anticoagulation from apixaban or rivaroxaban Andexanet alfa for reversing anticoagulation from apixaban or rivaroxaban T echnology appraisal guidance Published: 12 May 2021 www.nice.org.uk/guidance/ta697 © NICE 2021. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and-conditions#notice-of- rights).Your responsibility Your responsibility The recommendations in this guidance represent the view of NICE, arrived at after careful (...) a responsibility to promote an environmentally sustainable health and care system and should assess and reduce the environmental impact of implementing NICE recommendations wherever possible. Andexanet alfa for reversing anticoagulation from apixaban or rivaroxaban (TA697) © NICE 2021. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and- conditions#notice-of-rights). Page 2 of 23Contents Contents 1 Recommendations 4 2 Information about andexanet alfa 5 Marketing authorisation

2021 National Institute for Health and Clinical Excellence - Technology Appraisals

4. Intermediate-Dose versus Standard-Dose Prophylactic Anticoagulation in Patients with COVID-19 Admitted to the Intensive Care Unit: 90-Day Results from the INSPIRATION Randomized Trial Full Text available with Trip Pro

Intermediate-Dose versus Standard-Dose Prophylactic Anticoagulation in Patients with COVID-19 Admitted to the Intensive Care Unit: 90-Day Results from the INSPIRATION Randomized Trial Intermediate-Dose versus Standard-Dose Prophylactic Anticoagulation in Patients with COVID-19 Admitted to the Intensive Care Unit: 90-Day Results from the INSPIRATION Randomized Trial - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Clipboard (...) for external citation management software Create file Cancel Your RSS Feed Name of RSS Feed: Number of items displayed: Create RSS Cancel RSS Link Copy Actions Cite Display options Display options Format Share Permalink Copy Page navigation Thromb Haemost Actions . 2021 Apr 17. doi: 10.1055/a-1485-2372. Online ahead of print. Intermediate-Dose versus Standard-Dose Prophylactic Anticoagulation in Patients with COVID-19 Admitted to the Intensive Care Unit: 90-Day Results from the INSPIRATION Randomized Trial

2021 EvidenceUpdates

5. Tranexamic acid and bleeding in patients treated with non-vitamin K oral anticoagulants undergoing dental extraction: The EXTRACT-NOAC randomized clinical trial Full Text available with Trip Pro

Tranexamic acid and bleeding in patients treated with non-vitamin K oral anticoagulants undergoing dental extraction: The EXTRACT-NOAC randomized clinical trial Tranexamic acid and bleeding in patients treated with non-vitamin K oral anticoagulants undergoing dental extraction: The EXTRACT-NOAC randomized clinical trial - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Clipboard, Search History, and several other advanced (...) Create file Cancel Your RSS Feed Name of RSS Feed: Number of items displayed: Create RSS Cancel RSS Link Copy Actions Cite Display options Display options Format Share Permalink Copy Page navigation PLoS Med Actions . 2021 May 3;18(5):e1003601. doi: 10.1371/journal.pmed.1003601. eCollection 2021 May. Tranexamic acid and bleeding in patients treated with non-vitamin K oral anticoagulants undergoing dental extraction: The EXTRACT-NOAC randomized clinical trial , , , , , , , , , , , , Affiliations

2021 EvidenceUpdates

6. Oral Anticoagulant Agents in Patients With Atrial Fibrillation and CKD: A Systematic Review and Pairwise Network Meta-analysis

Oral Anticoagulant Agents in Patients With Atrial Fibrillation and CKD: A Systematic Review and Pairwise Network Meta-analysis Oral Anticoagulant Agents in Patients With Atrial Fibrillation and CKD: A Systematic Review and Pairwise Network Meta-analysis - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Clipboard, Search History, and several other advanced features are temporarily unavailable. COVID-19 Information Show (...) displayed: Create RSS Cancel RSS Link Copy Actions Cite Display options Display options Format Share Permalink Copy Page navigation Am J Kidney Dis Actions . 2021 Apr 16;S0272-6386(21)00530-8. doi: 10.1053/j.ajkd.2021.02.328. Online ahead of print. Oral Anticoagulant Agents in Patients With Atrial Fibrillation and CKD: A Systematic Review and Pairwise Network Meta-analysis , , , , , Affiliations Expand Affiliations 1 Division of Nephrology, Beijing Anzhen Hospital, Capital Medical University; Division

2021 EvidenceUpdates

7. Anticoagulation and In-Hospital Mortality From Coronavirus Disease 2019: A Systematic Review and Meta-Analysis Full Text available with Trip Pro

Anticoagulation and In-Hospital Mortality From Coronavirus Disease 2019: A Systematic Review and Meta-Analysis Anticoagulation and In-Hospital Mortality From Coronavirus Disease 2019: A Systematic Review and Meta-Analysis - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Clipboard, Search History, and several other advanced features are temporarily unavailable. COVID-19 Information Show account info Close Account Logged (...) Copy Actions Cite Display options Display options Format Share Permalink Copy Page navigation Meta-Analysis Clin Appl Thromb Hemost Actions . Jan-Dec 2021;27:10760296211008999. doi: 10.1177/10760296211008999. Anticoagulation and In-Hospital Mortality From Coronavirus Disease 2019: A Systematic Review and Meta-Analysis , , , , Affiliations Expand Affiliations 1 Department of Medicine, Faculty of Medicine, Chulalongkorn University and King Chulalongkorn Memorial Hospital, Thai Red Cross Society

2021 EvidenceUpdates

8. microINR for anticoagulation therapy

microINR for anticoagulation therapy microINR for anticoagulation therapy Medtech innovation briefing Published: 21 April 2021 www.nice.org.uk/guidance/mib257 pathways This advice should be read in conjunction with DG14. Summary Summary • The technology technology described in this briefing is the microINR. It is used for measuring international normalised ratio (INR) levels for people having anticoagulation therapy. • The innovative aspects innovative aspects are that the device offers (...) portable self-monitoring for coagulation with reduced blood sample needs and increased connectivity capabilities. • The intended place in therapy place in therapy would be as an alternative to hospital-based testing and alongside alternative point-of-care tests in people who need INR monitoring. • NICE's diagnostics guidance on atrial fibrillation and heart valve disease: self-monitoring coagulation status using point-of-care coagulometers looks at using other INR monitoring devices for anticoagulation

2021 National Institute for Health and Clinical Excellence - Advice

9. The Effectiveness and Safety of Direct Oral Anticoagulants Following Lower Limb Fracture Surgery: A Systematic Review and Meta-analysis

The Effectiveness and Safety of Direct Oral Anticoagulants Following Lower Limb Fracture Surgery: A Systematic Review and Meta-analysis The Effectiveness and Safety of Direct Oral Anticoagulants Following Lower Limb Fracture Surgery: A Systematic Review and Meta-analysis - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Clipboard, Search History, and several other advanced features are temporarily unavailable. COVID-19 (...) : Number of items displayed: Create RSS Cancel RSS Link Copy Actions Cite Display options Display options Format Share Permalink Copy Page navigation J Orthop Trauma Actions . 2021 Apr 1;35(4):217-224. doi: 10.1097/BOT.0000000000001962. The Effectiveness and Safety of Direct Oral Anticoagulants Following Lower Limb Fracture Surgery: A Systematic Review and Meta-analysis , , , , , Affiliations Expand Affiliations 1 Department of Orthopaedics, Regionshospitalet Randers, Randers, Denmark. 2 Department

2021 EvidenceUpdates

10. Anticoagulant therapy for splanchnic vein thrombosis: a systematic review and meta-analysis

Anticoagulant therapy for splanchnic vein thrombosis: a systematic review and meta-analysis Anticoagulant therapy for splanchnic vein thrombosis: a systematic review and meta-analysis - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Clipboard, Search History, and several other advanced features are temporarily unavailable. COVID-19 Information Show account info Close Account Logged in as: username Search: Search Save Email (...) options Display options Format Share Permalink Copy Page navigation Blood Actions . 2021 Mar 4;137(9):1233-1240. doi: 10.1182/blood.2020006827. Anticoagulant therapy for splanchnic vein thrombosis: a systematic review and meta-analysis , , , , , , , Affiliations Expand Affiliations 1 Department of Medical, Oral, and Biotechnological Sciences, "G. d'Annunzio" University, Chieti-Pescara, Italy. 2 Diagnostic and Therapeutic Medicine Department, University Campus Bio-Medico of Rome, Rome, Italy. 3

2021 EvidenceUpdates

11. American Society of Hematology 2021 guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19 Full Text available with Trip Pro

American Society of Hematology 2021 guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19 American Society of Hematology 2021 guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19 - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Clipboard, Search History, and several other advanced features are temporarily unavailable. COVID-19 is an emerging, rapidly (...) of RSS Feed: Number of items displayed: Create RSS Cancel RSS Link Copy Actions Cite Display options Display options Format Share Permalink Copy Page navigation Blood Adv Actions . 2021 Feb 9;5(3):872-888. doi: 10.1182/bloodadvances.2020003763. American Society of Hematology 2021 guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19 , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Affiliations Expand Affiliations 1 Department

2021 EvidenceUpdates

12. CIRSE Standards of Practice on Peri-operative Anticoagulation Management During Interventional Radiology Procedures

CIRSE Standards of Practice on Peri-operative Anticoagulation Management During Interventional Radiology Procedures CIRSE Standards of Practice on Peri-operative Anticoagulation Management During Interventional Radiology Procedures

2021 Cardiovascular and Interventional Radiological Society of Europe

13. Anticoagulant Treatment for Splanchnic Vein Thrombosis in Liver Cirrhosis: A Systematic Review and Meta-Analysis

Anticoagulant Treatment for Splanchnic Vein Thrombosis in Liver Cirrhosis: A Systematic Review and Meta-Analysis Anticoagulant Treatment for Splanchnic Vein Thrombosis in Liver Cirrhosis: A Systematic Review and Meta-Analysis - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Clipboard, Search History, and several other advanced features are temporarily unavailable. COVID-19 is an emerging, rapidly evolving situation (...) for external citation management software Create file Cancel Your RSS Feed Name of RSS Feed: Number of items displayed: Create RSS Cancel RSS Link Copy Actions Cite Display options Display options Format Share Permalink Copy Page navigation Thromb Haemost Actions . 2021 Feb 1. doi: 10.1055/s-0040-1722192. Online ahead of print. Anticoagulant Treatment for Splanchnic Vein Thrombosis in Liver Cirrhosis: A Systematic Review and Meta-Analysis , , , , , , , , , Affiliations Expand Affiliations 1 Department

2021 EvidenceUpdates

14. DOAC Dipstick for detecting direct oral anticoagulants

DOAC Dipstick for detecting direct oral anticoagulants DOAC Dipstick for detecting direct oral anticoagulants Medtech innovation briefing Published: 2 February 2021 www.nice.org.uk/guidance/mib248 pathways Summary Summary • The technology technology described in this briefing is the DOASENSE DOAC Dipstick. It is used for detecting direct oral anticoagulants (DOACs) in urine. • The innovative aspects innovative aspects are that the technology is a point-of-care test with results available within (...) . • The cost cost of the DOAC Dipstick is £15 per strip (excluding VAT). © NICE 2021. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and- conditions#notice-of-rights). Page 1 of 13The technology The technology The DOAC Dipstick (DOASENSE GmbH) is a single-use, point-of-care dipstick test that is used to detect direct oral anticoagulants (DOACs) in urine. The urine dipstick test detects DOACs (both factor Xa inhibitors and thrombin inhibitors) based on colour-changing

2021 National Institute for Health and Clinical Excellence - Advice

15. Effect of oral anticoagulant use on surgical delay and mortality in hip fracture

Effect of oral anticoagulant use on surgical delay and mortality in hip fracture Effect of oral anticoagulant use on surgical delay and mortality in hip fracture - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Clipboard, Search History, and several other advanced features are temporarily unavailable. COVID-19 is an emerging, rapidly evolving situation. National Institutes of Health National Library of Medicine National (...) Name of RSS Feed: Number of items displayed: Create RSS Cancel RSS Link Copy Actions Cite Display options Display options Format Share Permalink Copy Page navigation Meta-Analysis Bone Joint J Actions . 2021 Feb;103-B(2):222-233. doi: 10.1302/0301-620X.103B2.BJJ-2020-0583.R2. Effect of oral anticoagulant use on surgical delay and mortality in hip fracture , , , , , , , Affiliations Expand Affiliations 1 Department of Surgery, Section of Orthopaedic Surgery, University of Calgary, Calgary, Alberta

2021 EvidenceUpdates

16. Anticoagulant and Antiplatelet Therapy

Anticoagulant and Antiplatelet Therapy 2020 ACC Expert Consensus Decision Pathway for Anticoagulant and Antiplatelet Therapy in Patients With Atrial Fibrillation or Venous Thromboembolism Undergoing Percutaneous Coronary Intervention or With Atherosclerotic Cardiovascular Disease: A Report of the American College of Cardiology Solution Set Oversight Committee | Journal of the American College of Cardiology Search Quick Search anywhere Enter Search Terms Search Quick Search in Journals Enter (...) Search Terms Search Quick Search in Journals Enter Search Terms Search Quick Search in Journals Enter Search Terms Search Quick Search in Journals Enter Search Terms Search Quick Search in Journals Enter Search Terms Search Quick Search in Journals Enter Search Terms Search Quick Search in Journals Enter Search Terms Search Quick Search in Journals Enter Search Terms Search › › › 2020 ACC Expert Consensus Decision Pathway for Anticoagulant and Antiplatelet Therapy in Patients With Atrial Fibrillation

2021 American College of Cardiology

17. Poor evidence of direct anticoagulant (DOAC), DOAC and increased thrombosis without APS and COVID-19

Poor evidence of direct anticoagulant (DOAC), DOAC and increased thrombosis without APS and COVID-19 Page 52 · MED CHECK December 2020/ Vol.6 No.19 C N o 19 M ED HECK 2 0 2 0 Editorial Amateurism Review Poor evidence of direct anticoagulant (DOAC) DOAC and increased thrombosis without APS Candidates of New Products COVID-19 Vaccine Candidates Editorial Amateurism Review Warfarin is the standard treatment for non-valvular atrial fibrillation DOAC may induce more thrombosis in patients without (...) Introduction Prevalence of patients with non-valvular atrial fibrillation increases with age [1,2]. Incidence of stroke and coronary heart disease, cardiovascular mortality and overall mortality increases with each additional risk The usefulness of direct anticoagulants (DOACs) has not been proven Translated and revised from Med Check(in Japanese) Mar 2020 ; 20 (88):30-34 Summary ? Until 2010, warfarin, a vitamin K antagonist, was the only oral anticoagulant for the management of non-valvular atrial

2021 Med Check - The Informed Prescriber

18. Effectiveness and safety of direct-acting oral anticoagulants compared to vitamin K antagonists in patients with left ventricular thrombus: A meta-analysis

Effectiveness and safety of direct-acting oral anticoagulants compared to vitamin K antagonists in patients with left ventricular thrombus: A meta-analysis Effectiveness and safety of direct-acting oral anticoagulants compared to vitamin K antagonists in patients with left ventricular thrombus: A meta-analysis - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Clipboard, Search History, and several other advanced features (...) Jan;197:185-191. doi: 10.1016/j.thromres.2020.11.018. Epub 2020 Nov 20. Effectiveness and safety of direct-acting oral anticoagulants compared to vitamin K antagonists in patients with left ventricular thrombus: A meta-analysis , , , , Affiliations Expand Affiliations 1 Department of Cardiac Surgery, Shengjing Hospital of China Medical University, Shenyang, China. Electronic address: zhouk@sj-hospital.org. 2 Department of Ultrasound, Shengjing Hospital of China Medical University, Shenyang, China

2021 EvidenceUpdates

19. Management of anticoagulant services (Covid-19)

Management of anticoagulant services (Covid-19) Publications approval reference: 001559 Specialty guides for patient management during the coronavirus pandemic Clinical guide for the management of anticoagulant services during the coronavirus pandemic November 2020 As healthcare professionals we all have general responsibilities in relation to coronavirus and for these we should seek and act on national and local guidelines. We also have a specific responsibility to ensure that anticoagulant (...) care continues with the minimum burden on the NHS. We must engage with management and clinical teams planning the local response in our hospitals and across primary care. Anticoagulant services may not seem to be in the frontline with coronavirus but we do have a key role in continuing to keep patients on anticoagulants as safe as possible; this must be planned. In response to pressures on the NHS, the way we deliver anticoagulants may need to change. We should seek the best local solutions

2021 NHS England

20. Twice- or Once-Daily Dosing of Direct Oral Anticoagulants, a systematic review and meta-analysis

Twice- or Once-Daily Dosing of Direct Oral Anticoagulants, a systematic review and meta-analysis Twice- or Once-Daily Dosing of Direct Oral Anticoagulants, a systematic review and meta-analysis - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Clipboard, Search History, and several other advanced features are temporarily unavailable. COVID-19 is an emerging, rapidly evolving situation. Get the latest public health (...) of Direct Oral Anticoagulants, a systematic review and meta-analysis , , , , , , , , , , , , , Affiliations Expand Affiliations 1 Université de Lyon, Université Lyon 1, CNRS, Laboratoire de Biométrie et Biologie Evolutive UMR 5558, F-69622 Villeurbanne, France; Service de Médecine Interne et Vasculaire, Hôpital Lyon Sud, Hospices Civils de Lyon, Lyon, France. Electronic address: sabine.mainbourg@chu-lyon.fr. 2 Université de Lyon, Université Lyon 1, CNRS, Laboratoire de Biométrie et Biologie Evolutive

2020 EvidenceUpdates